Herein, our findings strongly suggest that RECA may offer therapeutic potential for the treatment of Alzheimer’s disease through inhibiting the AChE, inflammation, and oxidative stress activities. Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.